| Bioactivity | TDSRCVIGLYHPPLQVY TFA is a disordered control peptide. TDSRCVIGLYHPPLQVY TFA is a peptide containing the same amino acids as LP17 (HY-P3400) but in a different sequence order[1][2]. | ||||||
| Name | TDSRCVIGLYHPPLQVY TFA | ||||||
| Shortening | TDSRCVIGLYHPPLQVY | ||||||
| Formula | C91H138F3N23O27S | ||||||
| Molar Mass | 2075.27 | ||||||
| Appearance | Solid | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Gibot S, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004 Dec 6;200(11):1419-26. [2]. Xu P, et al. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis. 2019 Jul 19;10(8):555 |
TDSRCVIGLYHPPLQVY TFA
CAS: F: C91H138F3N23O27S W: 2075.27
TDSRCVIGLYHPPLQVY TFA is a disordered control peptide. TDSRCVIGLYHPPLQVY TFA is a peptide containing the same amino acid
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.